DEPATUXIZUMAB

UNII:	W984C353CG
Formula:
Preferred Substance Name:	DEPATUXIZUMAB
GSRS Full Record:	W984C353CG i

1471999-69-5
ABT-806
ANTI-EGFR MAB ABT-806
ANTI-EGFR MOAB ABT-806
ANTI-EGFR MONOCLONAL ANTIBODY ABT-806
DEPATUXIZUMAB [INN]
DEPATUXIZUMAB [USAN]
DEPATUXIZUMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL ABT-806 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL ABT-806 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS EGFR (EPIDERMAL GROWTH FACTOR RECEPTOR, RECEPTOR TYROSINE-PROTEIN KINASE ERBB-1, ERBB1, HER1, HER-1, ERBB)), HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODY GAMMA1 HEAVY CHAIN HUMANIZED (1-446) (HUMANIZED VH (HOMO SAPIENS IGHV4-30-4*01 (84.50%) -(IGHD)-IGHJ4*01) (9.7.9) (1-116) -HOMO SAPIENS IGHG1*01, G1M17,1 (CH1 (117-214), HINGE (215-229),CH2 (230-339), CH3 (340-444), CHS (445-446)) (117-446)), (219-214')-DISULFIDE WITH KAPPA LIGHT CHAIN CHIMERIC (1-214) (MUS MUSCULUS V-KAPPA (MUS MUSCULUS IGKV14-100*01 -IGKJ1*01) (6.3.9) (1'-107') -HOMO SAPIENS IGKC*01, KM3 (108'-214')) DIMER (225-225:228- 228)

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

DEPATUXIZUMAB

Synonyms and Mappings

Resources